Dual mode of degradation of Cdc25 A phosphatase
Abstract
The Cdc25 dual-specificity phosphatases control progression through the eukaryotic cell division cycle by activating cyclin-dependent kinases. Cdc25 A regulates entry into S-phase by dephosphorylating Cdk2, it cooperates with activated oncogenes in inducing transformation and is overexpressed in several human tumors. DNA damage or DNA replication blocks induce phosphorylation of Cdc25 A and its subsequent degradation via the ubiquitin–proteasome pathway. Here we have investigated the regulation of Cdc25 A in the cell cycle. We found that Cdc25 A degradation during mitotic exit and in early G1 is mediated by the anaphase-promoting complex or cyclosome (APC/C) ligase, and that a KEN-box motif in the N-terminus of the protein is required for its targeted degradation. Interestingly, the KEN-box mutated protein remains unstable in interphase and upon ionizing radiation exposure. Moreover, SCF (Skp1/Cullin/F-box) inactivation using an interfering Cul1 mutant accumulates and stabilizes Cdc25 A. The presence of Cul1 and Skp1 in Cdc25 A immunocomplexes suggests a direct involvement of SCF in Cdc25 A degradation during interphase. We propose that a dual mechanism of regulated degradation allows for fine tuning of Cdc25 A abundance in response to cell environment.
Acknowledgements
We thank Kristian Helin for providing Cdh1 and Cdc20 encoding plasmids and antibodies, and Zhen-Qiang Pan for providing the pCR3.1-Flag-Cul1(1–452) plasmid. We acknowledge Simona Ronzoni for fluorescence-activated cell sorting analysis. We gratefully acknowledge Marina Melixetian for helpful discussions and Andrea Musacchio for critical reading of the manuscript. This work was supported by grants from the NIH (R01-CA76584 and R01-GM57587) to M.P. and by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Consiglio Nazionale delle Ricerche (CNR), Fondazione Italiana per la Ricerca sul Cancro (FIRC) and Telethon to G.F.D. M.P. is a recipient of the Irma T.Hirschl Scholarship. M.D. and M.S. were supported by fellowships from the FIRC.

